Abstract: This article proposes design techniques for partially calibrated sparse linear subarrays and algorithms to perform direction-of-arrival (DOA) estimation. First, we introduce array ...
Background/objectives Rilonacept (RI), an interleukin (IL)-1α/β cytokine trap, is a biological treatment to prevent recurrence in recurrent pericarditis (RP). Discontinuation of RI in patients after ...
In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...
A Ukrainian special forces unit prepares a Ukraine-made drone for an aerial reconnaissance mission in the country's Zaporizhzhia region on May 23. Dmytro Smolienko/Ukrinform/Getty Images Ukraine said ...
Immunohistochemistry-based molecular subtyping in muscle-invasive bladder cancer: Predicting response to neoadjuvant chemotherapy. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.
Saudi Minister of Defense Prince Khalid bin Salman (center) meets with Major General Mohammad Bagheri, chief of staff of Iran’s Armed Forces (left), and Iranian Supreme Leader Ali Khamenei (right) on ...
To celebrate the 50th anniversary of the establishment of diplomatic relations between the Philippines and China, the Department of Foreign Affairs (DFA), the Chinese Embassy in the Philippines and ...
Outcomes of simultaneous, adaptive, MRI-guided liver SBRT in patients with heavily pretreated colorectal cancer and four or more liver metastases. Nelmastobart (hSTC810) combined with capecitabine ...
Medical workers attend to patients of the coronavirus disease (COVID-19) at an intensive care unit (ICU) converted from a conference room, at a hospital in Hebei province, China, January 11, 2023.
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results